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Background: Glucose is a more efficient substrate for ATP production than free fatty acid (FFA). Insulin resistance (IR) results in higher FFA 
concentrations and impaired myocardial glucose use, potentially worsening ischemia. We hypothesized that metabolic manipulation with a 
hyperinsulinemic euglycemic clamp (HEC) would affect a greater improvement in left ventricular (LV) performance during dobutamine stress echo 
(DSE) in subjects with IR.
Methods: 24 subjects with normal LV function and coronary disease (CAD) awaiting revascularization underwent 2 DSEs. Prior to one DSEs they 
underwent an HEC, where a primed infusion of insulin (rate 43mU.m-2.min-1) was co-administered with 20% dextrose at variable rates to maintain 
euglycemia. At steady-state the DSE was performed and images of the LV were acquired with tissue Doppler at each stage for offline analysis. 
Segmental peak systolic velocities (Vs) were recorded, as well as LV ejection fraction (EF). Subjects were then divided into two groups based on their 
insulin sensitivity during the HEC.
Results: HEC changed the metabolic environment, suppressing FFAs and thereby increasing glucose use. This resulted in improved LV performance 
at peak stress, measured by EF and peak Vs, that was greater in the subjects with IR (see table 1).
Conclusions: Increased myocardial glucose use induced by HEC improves LV function under stress in subjects with CAD and IR. Cardiac metabolic 
manipulation in subjects with IR is a promising target for future therapy.
Table 1: The Effects of HEC in the Insulin Resistant and Insulin Sensitive Groups. Means (SEM)
Insulin Sensitive Insulin Resistant
Average M Value
(mg/kg/min)
5.7 (0.4) 2.2 (0.3)
Control Clamp p (ctrl vs clamp) Control Clamp p (ctrl vs clamp)
Pre-DSE Glucose (mg/dl) 94 (4) 87 (3) 0.005 104 (4) 106 (3) ns
Pre-DSE FFA (micromol/l) 380 (67) 49 (16) 0.002 422 (76) 111 (25) 0.0006
Pre-DSE Insulin (pmol/l) 42.4 (4) 447 (25) <0.0001 90.7 (15) 624 (50) <0.0001
Peak DSE EF (%) 65.2 (1.8) 70.4 (1.8) 0.002 64.8 (2.1) 73.5 (1.7) <0.0001
Ischemic Segments Peak DSE Vs (cm/s) 8.6 (0.5) 9.3 (0.5) ns 5.9 (0.4) 6.7 (0.3) <0.0001
Non-ischemic Segments Peak DSE Vs (cm/s) 8.4 (0.4) 8.5 (0.3) ns 7.3 (0.4) 8.3 (0.4) 0.02
